Matinas BioPharma
Price & Volume
Stats
See moreOpen | $0.55 |
Previous Close | $0.57 |
Day Range | $0.55-$0.64 |
52W Range | $0.50-$18.49 |
Market Cap | $2.7M |
Shares Short | 32,365 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$13.4M |
Diluted EPS | -$4.74 |
News
See moreYahoo Finance • 2 years ago
Why Matinas BioPharma Stock Is Sinking Today
Yahoo Finance • 2 years ago
Compassionate Use Patient Treated with Matinas BioPharma’s MAT2203 and Showing Complete Clinical Resolution of Rare R. mucilaginosa Fungal Infection Featured in Oral Presentation at ECCMID
Yahoo Finance • 2 years ago
Matinas BioPharma to Webcast Conference Call to Discuss 2022 Financial Results and Provide a Business Update on March 15, 2023
Yahoo Finance • 2 years ago
Matinas BioPharma Announces that MAT2203 Will Be Featured in Two Oral Presentations at ECCMID
About
CEO | Mr. Jerome D. Jabbour J.D. |
Address | 1545 Route 206 South, Bedminster, NJ, United States, 07921 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 32 |
